Skip to main content

Differentiation Biomarkers of Osteoarthritis Determined by Glycoblotting

  • Living reference work entry
  • First Online:
Biomarkers in Bone Disease

Abstract

Drastic structural alteration of the cell surface glycans during cell differentiation can provide clinically potential biomarkers. Recently, there have been substantial advances in our understanding of the importance of the posttranslational protein glycosylations in various biological systems. However, we still do not fully understand the significance and mechanism of the glycoform changes during cellular proliferation and/or malignant alterations detected widely in many human diseases progress due to the difficulty of the structural analysis of highly complicated glycan structures. Moreover, the general and conventional procedures for the glycan analysis need extremely tedious and time-consuming multiple processes to enrich whole glycans directly from heterogeneous biological samples such as blood, body fluids, cultured cells, tissue/organ, and so on. As a result, the therapeutic/diagnostic potential of the dynamic disease-specific alterations in the posttranslational glycosylations has not been well exploited with a few notable exceptions. This chapter describes the advantage of the use of a key technology for the glycan-specific enrichment protocol, namely a “glycoblotting method,” in the discovery research of new class of human osteoarthritis cartilage-related biomarkers indicating the initiation of chondrocyte cell differentiation in the early stage of the cartilage degradation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AQP1:

Aquaporin-1

BOA:

Benzyloxyamine

CHO:

Chinese hamster ovary

ConA:

Concanavalin A

DMB:

1,2-diamino-4,5-methylene-dioxy-benzene

ENPP1:

Ectonucleotide pyrophosphatase/phosphodiesterase-1

ESCs:

Embryonic stem cells

iPSCs:

Induced pluripotent stem cells

MALDI:

Matrix-assisted laser desorption ionization

MS:

Mass spectrometry

MSCs:

Mesenchymal stem cells

NMR:

Nuclear magnetic resonance

OA:

Osteoarthritis

PCR:

Polymerase chain reaction

PNGase F:

Peptide N-glycosidase F

References

  • Alley WR, Mechref Y, Novotny MV. Use of activated graphitized carbon chips for liquid chromatography/mass spectrometric and tandem mass spectrometric analysis of tryptic peptides. Rapid Commun Mass Spectrom. 2009;23:495–505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Amano M, Yamaguchi M, Takegawa Y, Yamashita T, Terashima M, Furukawa J-i, Miura Y, Shinohara Y, Iwasaki N, Minami A, Nishimura S-I. Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell proliferation. Mol Cell Proteomics. 2010;9:523–37.

    Article  CAS  PubMed  Google Scholar 

  • Clouet J, Vinatier C, Merceron C, Pot-vaucel M, Maugars Y, Weiss P, Grimandi G, Guicheux J. From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov Today. 2009;14:913–25.

    Article  CAS  PubMed  Google Scholar 

  • Dai Z, Zhou J, Qiu S-J, Liu Y-K, Fan J. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein biomarkers. Electrophoresis. 2009;30:2957–66.

    Article  CAS  PubMed  Google Scholar 

  • Dube DH, Bertozzi CR. Glycans in cancer and inflammation: potential for therapeutics and diagnostics. Nat Rev Drug Discov. 2005;4:477–88.

    Article  CAS  PubMed  Google Scholar 

  • Gizaw ST, Koda T, Amano M, Kamimura K, Ohashi T, Hinou H, Nishimura S-I. A comprehensive glycome profiling of Huntington’s disease transgenic mice. Biochim Biophys Acta. 2015;1850:1704–18.

    Article  CAS  PubMed  Google Scholar 

  • Gizaw ST, Ohashi T, Tanaka M, Hinou H, Nishimura S-I. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer’s disease brain, serum and cerebrospinal fluid towards potential biomarker discovery. Biochim Biophys Acta. 2016;1860:1716–27.

    Google Scholar 

  • Halim A, Brinkmalm G, Ruetschi U, et al. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid. Proc Natl Acad Sci U S A. 2011;108:11848–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haltiwanger RS, Lowe JB. Role of glycosylation in development. Annu Rev Biochem. 2004;73:491–537.

    Article  CAS  PubMed  Google Scholar 

  • Hatakeyama S, Amano M, Tobisawa Y, Yoneyama T, Tsuchiya N, Habuchi T, Nishimura S-I, Ohyama C. Serum N-glycan alteration associated with renal cell carcinoma detected by high-throughput glycan analysis. J Urol. 2014;191:805–13.

    Article  CAS  PubMed  Google Scholar 

  • Hirose K, Amano M, Hashimoto R, Lee YC, Nishimura S-I. Insight into glycan diversity and evolutionary lineage based on comparative avio-N-glycomics and sialic acid analysis of 88 egg whites of Gallonaserae. Biochemistry. 2011;50:4757–74.

    Article  CAS  PubMed  Google Scholar 

  • Hunter DJ. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat Rev Rheumatol. 2011;7:13–22.

    Article  CAS  PubMed  Google Scholar 

  • Inafuku S, Noda K, Amano M, Murata M, Saito W, Ohashi T, Kanda A, Nishimura S-I, Ishida S. Alteration of N-glycan profiles in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015;56:5316–22.

    Article  CAS  PubMed  Google Scholar 

  • Inafuku S, Noda K, Amano M, Nishimura S-I, Ishida S. Increase of sialylated N-glycans in eyes with neovascular glaucoma secondary to proliferative diabetic retinopathy. Curr Eye Res. 2016;41:721–24.

    Google Scholar 

  • Ishibashi Y, Tobisawa Y, Hatakeyama S, Ohashi T, Tanaka M, Narita S, Koike T, Habuchi T, Nishimra S-I, Oyama C, Yoneyama T. Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer. Prostate. 2014;74:1521–9.

    Article  CAS  PubMed  Google Scholar 

  • Ishihara T, Kakiya K, Takahashi K, Miwa H, Rokushima M, Yoshinaga T, Tanaka T, Togame T, Takemoto H, Amano M, Iwasaki N, Minami A, Nishimura S-I. Discovery of novel differentiation markers in the early stage of chondrogenesis by glycoform-focused reverse proteomics and genomics. Biochim Biophys Acta. 2014;1840:645–55.

    Article  CAS  PubMed  Google Scholar 

  • Johnson K, Vaingankar S, Chen Y, Moffa A, Goldring MB, Sano K, Jin-Hua P, Sali A, Goding J, Terkeltaub R. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum. 1999;42:1986–97.

    Article  CAS  PubMed  Google Scholar 

  • Kamiyama T, Yokoo H, Furukawa JI, Kurogochi M, Togashi T, Miura N, Nakanishi K, Kamachi H, Kakisaka T, Tsuruga Y, Taketomi A, Nishimura S-I, Todo S. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Hepatology. 2013;57:2314–25.

    Article  CAS  PubMed  Google Scholar 

  • Kobata A, Endo T. Immobilized lectin columns: useful tools for the fractionation and structural analysis of oligosaccharides. J Chromatogr. 1992;597:111–22.

    Article  CAS  PubMed  Google Scholar 

  • Liang HT, Feng XC, Ma TH. Water channel activity of plasma membrane affects chondrocyte migration and adhesion. Clin Exp Pharmacol Physiol. 2008;35:7–10.

    Article  CAS  PubMed  Google Scholar 

  • Liu Y-C, Yen H-Y, Chen C-Y, Wong C-H, et al. Sialylation and fucosylation of epidermal growth factor suppress its dimerization and activation in lung cancer cells. Proc Natl Acad Sci U S A. 2011;108:11332–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matsuhashi T, Iwasaki N, Nakagawa H, Hato M, Kurogochi M, Majima T, Minami A, Nishimura S-I. Alteration of N-glycans related to articular cartilage deterioration after anterior cruciate ligament transection in rabbits. Osteoarthr Cart. 2008;16:772–8.

    Article  CAS  Google Scholar 

  • Miura Y, Hato M, Shinohara Y, Kuramoto H, Furukawa J-i, Kurogochi M, Shimaoka H, Tada M, Nakanishi K, Ozaki M, Todo S, Nishimura S-I. BlotGlycoABC™, an integrated glycoblotting technique for rapid and large scale clinical glycomics. Mol Cell Proteomics. 2008;7:370–7.

    Article  CAS  PubMed  Google Scholar 

  • Miyahara K, Nouso K, Saito S, Hiraoka S, Harada K, Takahashi S, Morimoto Y, Kobayashi S, Ikeda F, Miyake Y, Shiraha H, Takaki A, Amano M, Nishimura S-I, Yamamoto K. Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis. PLoS One. 2013;8:e74861.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miyahara K, Nouso K, Miyake Y, Nakamura S, Obi S, Amano M, Hirose K, Nishimura S-I, Yamamoto K. Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib. Hepatology. 2014;59:355–6.

    Article  CAS  PubMed  Google Scholar 

  • Nishimura S-I. Toward automated glycan analysis. Adv Carbohydr Chem Biochem. 2011;65:219–71.

    Article  CAS  PubMed  Google Scholar 

  • Nishimura S-I, Niikura K, Kurogochi M, Matsushita T, Fumoto M, Hinou H, Kamitani M, Nakagawa H, Deguchi K, Miura N, Monde K, Kondo H. High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectroscopy. Angew Chem Int Ed. 2005;44:91–6.

    Article  CAS  Google Scholar 

  • Nöth U, Steinert AF, Tuan RS. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol. 2008;4:371–80.

    PubMed  Google Scholar 

  • Nouso K, Amano M, Miyahara K, Ito MI, Morimoto Y, Kato H, Tsutsumi K, Tomoda T, Yamamoto N, Nakamura S, Kobayashi S, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Nakahara T, Nishimura S-I, Yamamoto K. Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer. J Gastroenterol. 2013;48:1171–9.

    Article  CAS  PubMed  Google Scholar 

  • Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006;126:855–67.

    Article  CAS  PubMed  Google Scholar 

  • Przyborski SA, Knowles BB, Ackerman SL. Embryonic phenotype of Unc5h3 mutant mice suggests chemorepulsion during the formation of the rostral cerebellar boundary. Development. 1998;125:41–50.

    CAS  PubMed  Google Scholar 

  • Rangappa S, Artigas G, Miyoshi R, Yokoi Y, Hayakawa S, Garcia-Martin F, Hinou H, Nishimura S-I. Effect of multiple O-glycosylation states on antibody recognition of the immunodominant motif in MUC1 extracellular tandem repeats. Med Chem Commun. 2016;7:1102–22.

    Google Scholar 

  • Rehan I, Ueda K, Mitani T, Amano M, Hinou H, Ohashi T, Kondo S, Nishimura S-I. Large-scale glycomics of livestock: discovery of highly sensitive serum biomarkers indicating an environmental stress affecting immune responses and productivity of Holstein dairy cows. J Agr Food Chem. 2015;63:10578–90.

    Article  CAS  Google Scholar 

  • Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005;52:2521–9.

    Article  PubMed  Google Scholar 

  • Terashima M, Amano M, Onodera T, Nishimura S-I, Iwasaki N. Quantitative glycomics monitoring of induced pluripotent- and embryonic stem cells during neuronal differentiation. Stem Cell Res. 2014;13:454–64.

    Article  CAS  PubMed  Google Scholar 

  • Uematsu R, Shinohara Y, Furukawa J-i, Nakagawa H,tpdel Shimaoka H, Deguchi K, Monde K, Nishimura S-I. High throughput quantitative glycomics and glycoform-focused proteomics of murine dermis and epidermis. Mol Cell Proteomics. 2005;4:1977–89.

    Google Scholar 

  • Uematsu R, Shinohara Y, Nakagawa H, Kurogochi M, Furukawa J-i, Miura Y, Akiyama M, Shimizu H, Nishimura S-I. Glycosylation specific for adhesion molecules in epidermis and its receptor revealed by glycoform-focused reverse genomics. Mol Cell Proteomics. 2009;8:232–44.

    Article  CAS  PubMed  Google Scholar 

  • Urita A, Matsuhashi T, Onodera T, Nakagawa H, Hato M, Amano M, Seito N, Minami A, Nishimura S-I, Iwasaki N. Alterations of high-mannose type N-glycosylation in human and mouse osteoarthritis cartilage. Arthritis Rheumatol. 2011;63:3428–38.

    Article  CAS  Google Scholar 

  • Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis – an untreatable disease? Nat Rev Drug Discov. 2005;4:331–44.

    Article  CAS  PubMed  Google Scholar 

  • Yamasaki Y, Nouso K, Miyahara K, Wada N, Dohi C, Morimoto Y, Takeuchi Y, Yasunaka T, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Amano M, Nishimura S-I, Yamamoto K. Use of noninvasive serum glycan markers to distinguish nonalcoholic steatohepatitis from simple steatosis. J Gastoentol Hepatol. 2015;30:528–34.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shin-Ichiro Nishimura , Takeshi Ishihara or Norimasa Iwasaki .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media B.V.

About this entry

Cite this entry

Nishimura, SI., Ishihara, T., Iwasaki, N. (2016). Differentiation Biomarkers of Osteoarthritis Determined by Glycoblotting. In: Preedy, V. (eds) Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7745-3_50-1

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-7745-3_50-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Online ISBN: 978-94-007-7745-3

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics